In this study, EGFR germline and somatic variants were retrospectively reviewed in 31,906 patients with lung cancer whose tumor tissues or peripheral blood samples were collected to perform a matched tumor-normal next-generation sequencing of 1,021 cancer-related genes. The gene discussed is EGFR; the disease is cancer.